ALS community to have a say in brain-computer interface development

Team Gleason and Precision partner to address everyday communication needs

Written by Margarida Maia, PhD |

Close-up of two people shaking hands, one wearing a gray suit jacket and the other a light blue shirt.

Precision Neuroscience and Team Gleason are partnering to give people with ALS a voice in developing brain-computer interface technology. (Photo from iStock)

  • Precision Neuroscience and Team Gleason partnered to involve the ALS community directly in shaping a new brain-computer interface (BCI) device.
  • ALS causes progressive muscle weakness and paralysis, affecting movement and speech, although thinking and understanding often remain intact.
  • The Layer 7 BCI system is being developed to help people communicate and control devices using brain signals, without penetrating brain tissue.

Precision Neuroscience and the nonprofit Team Gleason are partnering to give people with amyotrophic lateral sclerosis (ALS), their families, and caregivers a direct role in shaping a brain-computer interface (BCI).

Precision is developing the BCI system for people with severe paralysis caused by conditions including ALS and traumatic spinal cord injury. It aims to help them communicate and control electronic devices using only brain signals.

Recommended Reading
Illustration of a patient discussing treatment options and medical care with a healthcare professional.

ALS risk linked to wide range of lifestyle and health factors in study

ALS community to help guide technology development

The partnership will give the ALS community a direct way to share experiences and feedback with Precision as it develops its BCI system, Layer 7. Precision and Team Gleason also plan to offer educational activities for the ALS community and healthcare professionals, beginning with a joint appearance at the American Speech-Language-Hearing Association conference in Indianapolis this week.

“Through this partnership, the ALS community will have a direct say in how we build Layer 7,” Jayme Strauss, Precision’s chief clinical officer, said in a company press release.

For Strauss, the initiative also has a personal motivation: “I watched ALS take my father-in-law’s voice, and everything else. By the end, he couldn’t tell his grandkids he loved them or ask them about their day, even though he was still fully there, still wanting to. Experiences like his are why people living with ALS and their caregivers need a real voice in shaping the assistive technology built for them.”

ALS gradually damages the nerve cells that control movement, causing symptoms such as muscle weakness and difficulty walking. As the disease progresses, many people also lose the ability to speak and communicate, although their ability to think and understand often remains intact.

BCIs aim to bypass these physical limitations by using brain signals to let people control computers and other electronic devices without having to move or speak.

Precision’s Layer 7 technology uses a thin sheet of electrodes placed on the brain’s surface to detect electrical activity without penetrating the tissue. The system is designed to turn brain signals into digital commands, potentially enabling people with severe paralysis to interact with computers and other devices.

Early study shows brain signals can control digital tasks

In preliminary tests involving people undergoing neurosurgery, Layer 7 recorded brain signals that enabled computer programs to identify which of four words a participant spoke aloud and, in separate tests, decode the direction participants intended to move a cursor on a screen. In another group of patients, researchers reported that the temporary implantation procedure was fully reversible, meaning the device could be removed.

Through the partnership, people with ALS, their families, and caregivers will have a structured way to share their experiences with Precision. Their feedback will help the company better understand their needs and which features could make its technology more useful in everyday life.

“We’ve seen what happens when someone retains the ability to pursue their purpose in life, their ability to do the unthinkable, to tell their family, ‘I love you.’ That only happens when innovators design alongside the community it is intended to serve. Precision is building with our community, not just for it, and that is the kind of partnership that changes lives. Until there’s a cure, we will keep pushing what’s possible,” said Blair Casey, CEO of Team Gleason.

Leave a comment

Fill in the required fields to post. Your email address will not be published.

Comments are moderated. Once approved, your comment and username will be publicly visible. Please avoid sharing personal health information or other sensitive details.